| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/08/2007 | WO2007028117A2 P8 as a marker for heart failure |
| 03/08/2007 | WO2007028106A2 Host cell lines for production of antibody constant region with enhanced effector function |
| 03/08/2007 | WO2007027774A1 Targeting of herpes simplex virus to specific receptors |
| 03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
| 03/08/2007 | WO2007026362A2 Cross-linked polysaccharide and protein matrices and methods for their preparation |
| 03/08/2007 | WO2007026236A2 Electrotransfer of nucleic acid into tissue cells |
| 03/08/2007 | WO2007025554A1 Method for the generation of antigen-specific t-cells and uses thereof |
| 03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
| 03/08/2007 | WO2006127585A3 Transduction of primary cells |
| 03/08/2007 | WO2006113382A3 Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
| 03/08/2007 | WO2006096815A3 NOVEL hTMC PROMOTER AND VECTORS FOR THE TUMOR-SELECTIVE AND HIGH-EFFICIENT EXPRESSION OF CANCER THERAPEUTIC GENES |
| 03/08/2007 | WO2006034433A3 Delivery of polynucleotides |
| 03/08/2007 | WO2005094415A3 Recombinant vectors and methods for inducing an immune response |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | US20070054961 Factor |
| 03/08/2007 | US20070054873 Glucocorticoid modulation of nucleic acid-mediated immune stimulation |
| 03/08/2007 | US20070054872 Regulatable or conditional expression systems |
| 03/08/2007 | US20070054871 Method and apparatus for device controlled gene expression for cardiac protection |
| 03/08/2007 | US20070054869 Antisense modulation of superoxide dismutase 1, soluble expression |
| 03/08/2007 | US20070054860 Use of human chorionic gonadotropin (hCG)-derived peptides; reperfusion injuries; NF-kappa B-down-regulating peptide |
| 03/08/2007 | US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation |
| 03/08/2007 | US20070054858 Method of treating hepatocellular carcinoma |
| 03/08/2007 | US20070054856 Compositions and methods of using angiopoietin-like 4 protein |
| 03/08/2007 | US20070054849 Method for diagnosing hepatocellular carcinomas |
| 03/08/2007 | US20070054848 Composition and method for nerve regeneration |
| 03/08/2007 | US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/08/2007 | US20070054401 Composition for intracellular transport of biological particles or macromolecules |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054336 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 03/08/2007 | US20070054333 for identification on human chromosome 10 of a tumor suppressor gene; |
| 03/08/2007 | US20070054307 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 03/08/2007 | US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction |
| 03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053987 Cross-linked polysacharide and protein matrices and methods for their preparation |
| 03/08/2007 | US20070053935 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection |
| 03/08/2007 | US20070053928 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 03/08/2007 | US20070053926 Antigenic neisserial peptides |
| 03/08/2007 | US20070053923 Dna vaccine composition with enhanced immunogenicity |
| 03/08/2007 | US20070053921 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053913 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
| 03/08/2007 | US20070053911 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 03/08/2007 | US20070053910 Modulation of s6 kinase activity for the treatment of obesity |
| 03/08/2007 | US20070053903 Methods of using pHHLA2 to co-stimulate T-cells |
| 03/08/2007 | US20070053891 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 03/08/2007 | US20070053890 Canine embryonic stem cells |
| 03/08/2007 | US20070053889 Il-10 gene transfer to peripheral mononuclear cells |
| 03/08/2007 | US20070053887 Method for production of neuroblasts |
| 03/08/2007 | US20070053880 Growth differentiation factor-16 |
| 03/08/2007 | US20070053879 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 03/08/2007 | US20070053844 Formulations for alteration of biophysical properties of mucosal lining |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | DE112004002170T5 Verbesserte Verfahren und Zusammensetzungen für RNA Interferenz Improved methods and compositions for RNA interference |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
| 03/08/2007 | CA2621236A1 Host cell lines for production of antibody constant region with enhanced effector function |
| 03/08/2007 | CA2619783A1 Electrotransfer of nucleic acid into tissue cells |
| 03/07/2007 | EP1760154A2 sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell |
| 03/07/2007 | EP1760153A2 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 03/07/2007 | EP1760151A1 An improved method for the production and purification of adenoviral vectors |
| 03/07/2007 | EP1760144A2 Cartilage and bone repair composition |
| 03/07/2007 | EP1759714A1 Electrotransfer of nucleic acid into tissue cells |
| 03/07/2007 | EP1759013A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 03/07/2007 | EP1758999A1 METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA |
| 03/07/2007 | EP1758998A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 03/07/2007 | EP1758925A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 03/07/2007 | EP1758615A2 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 03/07/2007 | EP1758614A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof |
| 03/07/2007 | EP1758612A2 Composition comprising intercalated functional-active organic compounds |
| 03/07/2007 | EP1758595A2 Use of lipid conjugates in the treatment of diseases |
| 03/07/2007 | EP1531842A4 Regulation of cell growth by muc1 |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1228202B1 Antisense compositions and cancer-treatment methods |
| 03/07/2007 | EP1210445B1 Recombinant microorganisms |
| 03/07/2007 | EP1023048B1 Methods for encapsulating nucleic acids in lipid bilayers |
| 03/07/2007 | EP1007638B1 Kcnq potassium channels and methods of modulating same |
| 03/07/2007 | EP1003784B1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 03/07/2007 | EP0946713B1 Method for in vitro preconditioning of myoblasts before transplantation |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1925872A Method of preventing ultraviolet ray-induced apoptosis |
| 03/07/2007 | CN1925870A DNA vaccine expressing HA1 of equine-2 influenza virus |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1925750A Modulation of LINE-1 reverse transcriptase |
| 03/07/2007 | CN1924014A Interference RNA sequence of specificity interference MTA1 mRNA for inhibiting tumor metastasis |
| 03/07/2007 | CN1923289A Hybrid yeast avian influenza vaccine |
| 03/07/2007 | CN1923288A Hybrid yeast influenza vaccine |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186699 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 03/06/2007 | US7186698 Focusing ultrasonic frequency; magnetic resonance imaging |
| 03/06/2007 | US7186697 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 03/06/2007 | US7186694 Modulation body weights; dietetics; eating disorders |
| 03/06/2007 | US7186559 Apparatus and method for electroporation of biological samples |
| 03/06/2007 | US7186556 Modulating transcription of genes in vascular cells |
| 03/06/2007 | US7186550 Artificial nucleotide sequences for use as tools in gene therapy |
| 03/06/2007 | US7186534 Screening for predisposition to cancer, screening for enzyme inhibitors |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186412 Fusion proteins of Mycobacterium tuberculosis |
| 03/06/2007 | US7186409 Neural stem cells and use thereof for brain tumor therapy |
| 03/06/2007 | US7186408 Immunomodulators; for treatment of inflammation |